Michael Kappelman, MD, MPH^
The University of North Carolina at Chapel Hill^
Comparative Effectiveness of Biologic or Small Molecule Therapies in IBD
^Angela Dobes, MPH, was the original principal investigator on this project, and its original organization was the Crohn's & Colitis Foundation in New York.
Populations Populations PCORI is interested in research that seeks to better understand how different clinical and health system options work for different people. These populations are frequently studied in our portfolio or identified as being of interest by our stakeholders. View Glossary
Funding Opportunity Type
Intervention Strategy Intervention Strategies PCORI funds comparative clinical effectiveness research (CER) studies that compare two or more options or approaches to health care, or that compare different ways of delivering or receiving care. View Glossary
Last updated: March 4, 2022